Carbachol ophthalmic Alternatives Compared
Carbachol ophthalmic | Combigan (brimonidine / timolol) | Acetazolamide |
|
---|
Carbachol ophthalmic | Combigan (brimonidine / timolol) | Acetazolamide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Glaucoma, Intraocular Hypertension, Production of Miosis. Carbachol ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma, Glaucoma/Intraocular Hypertension, Intraocular Hypertension. Combigan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma, Hydrocephalus, Edema, Epilepsy, Hypokalemic Periodic Paralysis, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri, Seizure Prevention, Seizures. Acetazolamide may... View more |
Related suggestions |
|||||||||||||||
More about Carbachol ophthalmic | More about Combigan (brimonidine / timolol) | More about Acetazolamide | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Combigan has an average rating of 4.8 out of 10 from a total of 25 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 48% reported a negative effect. |
Acetazolamide has an average rating of 6.3 out of 10 from a total of 188 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Combigan prices |
View all Acetazolamide prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Carbastat, Carboptic, Isopto Carbachol, Miostat |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
N/A |
7 hours |
4 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 105 drugs are known to interact with Carbachol ophthalmic:
|
A total of 540 drugs are known to interact with Combigan:
|
A total of 263 drugs are known to interact with Acetazolamide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
September 28, 1972 |
October 30, 2007 |
July 27, 1953 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
||||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.